Cited by 1,023TGF-β signaling in diseasesT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.

TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Open access

Yang, Li, Pang, Yanli, Moses, Harold L.·2010·Trends in Immunology

DOI 10.1016/j.it.2010.04.002PMC PMC2891151

Open this paper in CoChat — free account

Abstract

Transforming growth factor beta (TGF-beta) plays an important role in tumor initiation and progression, functioning as both a suppressor and a promoter. The mechanisms underlying this dual role of TGF-beta remain unclear. TGF-beta exerts systemic immune suppression and inhibits host immunosurveillance. Neutralizing TGF-beta enhances CD8+ T-cell- and NK-cell-mediated anti-tumor immune responses. It also increases neutrophil-attracting chemokines resulting in recruitment and activation of neutrophils with an antitumor phenotype. In addition to its systemic effects, TGF-beta regulates infiltration of inflammatory/immune cells and cancer-associated fibroblasts in the tumor microenvironment causing direct changes in tumor cells. Understanding TGF-beta regulation at the interface of tumor and host immunity should provide insights into developing effective TGF-beta antagonists and biomarkers for patient selection and efficacy of TGF-beta antagonist treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.it.2010.04.002

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer-related inflammation
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
IL-17 and th17 cells
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
TGFβ in Cancer
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L. E., Worthen, G. S., & Albelda, S. Μ. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,470
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087

Show all 87 references

Sorted by citations

Items 201–300 of 1,000

Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy
Workenhe, S. T., Pol, J. G., Lichty, B. D., Cummings, D. T., & Mossman, K. L. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0059-t · Cited by 71
Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation
Gorchs, L., Hellevik, T., Bruun, J., Camilio, K. A., Al‐Saad, S., Stuge, T. B., & Martínez-Zubiaurre, I. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00087 · Cited by 71
MiR‐141‐3p‐Functionalized Exosomes Loaded in Dissolvable Microneedle Arrays for Hypertrophic Scar Treatment
Meng, S., Wei, Q., Chen, S., Liu, X., Cui, S., Huang, Q., Chu, Z., Ma, K., Zhang, W., Hu, W., et al. (2023) · Small · doi:10.1002/smll.202305374 · Cited by 71
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer
Roane, B. M., Arend, R. C., & Birrer, M. J. (2019) · Cancers · doi:10.3390/cancers11050668 · Cited by 70
MicroRNA-92 Expression in CD133+ Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGFβ
Shidal, C., Singh, N. P., Nagarkatti, P. S., & Nagarkatti, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2659 · Cited by 71
Alzheimer′s Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae , Other Suspect Pathogens, and the Immune System
Carter, C. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/501862 · Cited by 70
Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance
Skov, V., Larsen, T. S., Thomassen, M., Riley, C. H., Jensen, M. K., Bjerrum, O. W., Kruse, T. A., & Hasselbalch, H. C. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.07.009 · Cited by 68
Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity
Wagner, J. A., Wong, P., Schappe, T., Berrien-Elliott, M. M., Cubitt, C. C., Jaeger, N., Lee, M. J., Keppel, C. R., Marín, N. D., Foltz, J. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107720 · Cited by 69
Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis
Gu, S., Zaidi, S., Hassan, M. I., Mohammad, T., Malta, T. M., Noushmehr, H., Nguyen, B., Crandall, K. A., Srivastav, J., Obias, V., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.023 · Cited by 63
Identification of gastric cancer subtypes based on pathway clustering
Li, L., & Wang, X. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00186-z · Cited by 64
Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration
Xu, Y., Feng, L., Wang, S., Zhu, Q., Zheng, Z., Xiang, P., He, B., & Tang, D. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.05.041 · Cited by 65
Toward precision medicine of breast cancer
Carels, N., Spinassé, L. B., Tilli, T. M., & Tuszyński, J. A. (2016) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-016-0035-4 · Cited by 65
A Critical Role for Transcription Factor Smad4 in T Cell Function that Is Independent of Transforming Growth Factor β Receptor Signaling
Gu, A.-D., Zhang, S., Wang, Y., Xiong, H., Curtis, T. A., & Wan, Y. Y. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.019 · Cited by 63
The role played by the microenvironment in site-specific metastasis
Klein-Goldberg, A., Maman, S., & Witz, I. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.029 · Cited by 64
Adoptive T-Cell Immunotherapy
Gottschalk, S. M., Bollard, C. M., & Rooney, C. M. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2026_345 · Cited by 64
The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target
Yang, Y., Ye, W.-L., Zhang, R., He, X., Wang, J., Liu, Y., Wang, Y., Yang, X., Zhang, Y., & Gan, W.-J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6675208 · Cited by 66
Platelet cancer cell interplay as a new therapeutic target
Morris, K., Schnoor, B., & Papa, A. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188770 · Cited by 63
Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience
Luo, H., Ge, H., Cui, Y., Zhang, J., Fan, R., Zheng, A., Zheng, X., & Sun, Y. (2017) · Journal of Cancer · doi:10.7150/jca.21703 · Cited by 63
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
Kaliński, P., Muthuswamy, R., & Urban, J. A. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.22 · Cited by 67
Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy
Mirzaei, H. R., Pourghadamyari, H., Rahmati, M., Mohammadi, A., Nahand, J. S., Rezaei, A., Mirzaei, H., & Hadjati, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.010 · Cited by 62
Distinct eosinophil cytokine expression patterns in skin diseases – the possible existence of functionally different eosinophil subpopulations
Roth, N., Stadler, S., Lemann, M., Hösli, S., Simon, H., & Simon, D. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02694.x · Cited by 62
Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment
Poggi, A. D., & Giuliani, M. (2016) · Vaccines · doi:10.3390/vaccines4040041 · Cited by 64
Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges
Goto, T. (2019) · Vaccines · doi:10.3390/vaccines7030100 · Cited by 64
Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesicles
Halder, L. D., Jo, E. A. H., Hasan, M. Z., Ferreira‐Gomes, M., Krüger, T., Westermann, M., Palme, D. I., Rambach, G., Beyersdorf, N., Speth, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16241-5 · Cited by 61
Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer
Means, A. L., Freeman, T. J., Zhu, J., Woodbury, L. G., Smith, P. M., Wu, C., Meyer, A. R., Weaver, C., Padmanabhan, C., An, H., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.05.006 · Cited by 59
Early intervention with faecal microbiota transplantation: an effective means to improve growth performance and the intestinal development of suckling piglets
Cheng, C., Wei, H., Wang, P., Yu, H., Zhang, X. M., Jiang, S., & Peng, J. (2018) · animal · doi:10.1017/s1751731118001611 · Cited by 65
Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions
Kravchenko, J. S., Corsini, E., Williams, M. A., Decker, W. K., Manjili, M. H., Otsuki, T., Singh, N., Al‐Mulla, F., Al-Temaimi, R. A., Amedei, A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv033 · Cited by 60
Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer
Duan, J., Zhang, H., Qu, Y., Deng, T., Huang, D., Liu, R., Zhang, L., Bai, M., Zhou, L., Ying, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9936 · Cited by 60
Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment
Wang, X., Zhang, Y., Mu, X., Tu, C. R., Chung, Y., Tsao, S. W., Chan, G., Leung, W. H., Lau, Y., Liu, Y., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003832 · Cited by 61
Cardiac Intercellular Communication: Are Myocytes and Fibroblasts Fair-Weather Friends?
Martin, M. L., & Blaxall, B. C. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9404-5 · Cited by 62
The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Grusch, M., Petz, M., Metzner, T., Öztürk, D. G., Schneller, D., & Mikulits, W. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357943 · Cited by 57
Transforming Growth Factor-β1 and -β2 in Gastric Precancer and Cancer and Roles in Tumor-Cell Interactions with Peripheral Blood Mononuclear Cells In Vitro
Ma, G., Miao, Q., Zeng, X., Luo, T., Ma, L., Liu, Y., Lian, J., Gao, H., & Chen, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054249 · Cited by 59
Neutralizing Murine TGFβR2 Promotes a Differentiated Tumor Cell Phenotype and Inhibits Pancreatic Cancer Metastasis
Ostapoff, K. T., Cenik, B. K., Wang, M., Ye, R., Xu, X. N., Nugent, D. P., Hagopian, M. M., Topalovski, M., Rivera, L. B., Carroll, K. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1807 · Cited by 59
The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
Bayati, F., Mohammadi, M., Valadi, M., Jamshidi, S., Foma, A. M., & Sharif‐Paghaleh, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585819 · Cited by 59
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Zhang, Y., Zhou, W., Yang, J., Yang, J., & Wang, W. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00431-0 · Cited by 58
Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells
Wang, X., Brown, N. K., Wang, B., Shariati, K., Wang, K., Fuchs, S., Melero‐Martin, J. M., & Ma, M. (2021) · Advanced Science · doi:10.1002/advs.202003708 · Cited by 57
Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors
Bielecki, P. A., Lorkowski, M. E., Becicka, W. M., Atukorale, P. U., Moon, T. J., Zhang, Y., Wiese, M. L., Covarrubias, G., Ravichandran, S., & Karathanasis, E. (2020) · Nanoscale Horizons · doi:10.1039/d0nh00446d · Cited by 58
Functions and mechanisms of lactylation in carcinogenesis and immunosuppression
Su, J., Zheng, Z., Bian, C., Chang, S., Bao, J., Yu, H., Xin, Y., & Jiang, X. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1253064 · Cited by 57
Platelets Alter Tumor Cell Attributes to Propel Metastasis: Programming in Transit
Gay, L. J., & Felding‐Habermann, B. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.001 · Cited by 57
TGF β : A player on multiple fronts in the tumor microenvironment
Čaja, F., & Vannucci, L. E. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2014.945667 · Cited by 56
Genetic instability in the tumor microenvironment: a new look at an old neighbor
Palumbo, A., Costa, N. M. D., Bonamino, M., Pinto, L. F. R., & Nasciutti, L. E. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0409-y · Cited by 60
Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles
Casals, E., Gustà, M. F., Cobaleda‐Siles, M., García, A., & Puntes, V. (2017) · Cancer Nanotechnology · doi:10.1186/s12645-017-0030-4 · Cited by 56
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Ruan, S., Huang, Y., He, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202200027 · Cited by 54
Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion
Shao, X., Hua, S., Feng, T., Ocansey, D. K. W., & Yin, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911789 · Cited by 60
Smoking as a contributing factor for development of polycythemia vera and related neoplasms
Hasselbalch, H. C. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.09.002 · Cited by 55
Explaining the unexplainable: discrepancies in results from the CALGB/SWOG 80405 and FIRE-3 studies
Aderka, D., Stintzing, S., & Heinemann, V. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30172-x · Cited by 55
Fermented milk with probiotic Lactobacillus rhamnosus S1K3 (MTCC5957) protects mice from salmonella by enhancing immune and nonimmune protection mechanisms at intestinal mucosal level
Kemgang, T. S., Kapila, S., Shanmugam, V. P., Reddi, S., & Kapila, R. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.11.018 · Cited by 52
High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor‑positive breast cancer
Katsuta, E., Maawy, A. A., Yan, L., & Takabe, K. (2019) · Oncology Reports · doi:10.3892/or.2019.7275 · Cited by 53
Crosstalk Between Inflammatory Signaling and Methylation in Cancer
Das, D., Karthik, N., & Taneja, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.756458 · Cited by 54
Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy
Desai, N., Sahel, D. K., Sawant, B. K. S., Postwala, H. I., Shah, Y. B., Chavda, V. P., Fernandes, C., Khatri, D. K., & Vora, L. K. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400370 · Cited by 57
An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer
Raz, Y., & Erez, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.022 · Cited by 55
LY2157299 Monohydrate, a TGF-βR1 Inhibitor, Suppresses Tumor Growth and Ascites Development in Ovarian Cancer
Zhang, Q., Hou, X., Evans, B. J., VanBlaricom, J. L., Weroha, S. J., & Cliby, W. A. (2018) · Cancers · doi:10.3390/cancers10080260 · Cited by 54
Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy
Wang, T., Shen, Y., Luyten, S., Yang, Y., & Jiang, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104876 · Cited by 53
Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma
He, F., Chen, Z., Deng, W., Zhan, T., Huang, X., Zheng, Y., & Yang, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107789 · Cited by 51
Th3 Immune responses in the progression of leprosy via molecular cross-talks of TGF-β, CTLA-4 and Cbl-b
Kumar, S., Naqvi, R. A., Khanna, N., Pathak, P., & Rao, D. N. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.06.007 · Cited by 56
Radiation-induced bystander and systemic effects serve as a unifying model system for genotoxic stress responses
Burdak‐Rothkamm, S., & Rothkamm, K. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.08.001 · Cited by 54
Non-circadian aspects of BHLHE40 cellular function in cancer
Kiss, Z., Mudryj, M. M., & Ghosh, P. (2020) · Genes & Cancer · doi:10.18632/genesandcancer.201 · Cited by 53
Nanomedicine for T‐Cell Mediated Immunotherapy
Li, F., Ouyang, J., Chen, Z., Zhou, Z., Essola, J. M., Ali, B., Wu, X., Zhu, M., Guo, W., & Liang, X. (2023) · Advanced Materials · doi:10.1002/adma.202301770 · Cited by 51
Tumor-Primed NK Cells: Waiting for the Green Light
Sabry, M., & Lowdell, M. W. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00408 · Cited by 50
Why are epididymal tumours so rare?
Yeung, C., Wang, K., & Cooper, T. G. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.20 · Cited by 50
Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases
Parisi, L., Bassani, B., Tremolati, M., Gini, E., Farronato, G., & Bruno, A. (2017) · Journal of Immunology Research · doi:10.1155/2017/4218254 · Cited by 57
Transdermal treatment of the surgical and burned wound skin via phytochemical-capped gold nanoparticles
Lee, J., Kim, J., Go, J., Lee, J. H., Han, D.-W., DaeYoun, H., & Lee, J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.058 · Cited by 49
SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation
Hanna, D. N., Smith, P. M., Novitskiy, S. V., Washington, M. K., Zi, J., Weaver, C., Hamaamen, J. A., Lewis, K. B., Zhu, J., Yang, J., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.07.016 · Cited by 50
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β
Chaudhry, K., Geiger, A. E., Dowlati, E. P., Lang, H., Sohai, D. K., Hwang, E. I., Lazarski, C. A., Yvon, E. S., Holdhoff, M., Jones, R., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.10.010 · Cited by 49
Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update
Zu, X., Zhang, Q., Cao, R., Liu, J., Zhong, J., Wen, G., & Cao, D. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1225-3 · Cited by 48
Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer
Topalovski, M., Hagopian, M., Wang, M., & Brekken, R. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730945 · Cited by 49
TGFβ2 is a prognostic‐related biomarker and correlated with immune infiltrates in gastric cancer
Xiao, Z., Hu, L., Yang, L., Wang, S., Gao, Y., Zhu, Q., Yang, G., Huang, D., & Xu, Q. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15164 · Cited by 47
Self-citation
CAF cellular glycolysis: linking cancer cells with the microenvironment
Roy, A., & Bera, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5049-3 · Cited by 47
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications
Ulisse, S., Tuccilli, C., Sorrenti, S., Antonelli, A., Fallahi, P., D’Armiento, E., Catania, A., Tartaglia, F., Amabile, M. I., Giacomelli, L., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061405 · Cited by 46
Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma
Li, Y., Zhao, Z., Liu, H., Fetse, J., Jain, A., Lin, C., & Cheng, K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15116 · Cited by 47
Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer
Huang, H., & Brekken, R. A. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00079.2020 · Cited by 49
Inflammation and Cancer
Todoric, J., Umemura, A., Taniguchi, K., & Karin, M. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm027 · Cited by 46
The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer
Subtil, B., Cambi, A., Tauriello, D. V. F., & de Vries, I. J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.724883 · Cited by 45
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Li, R., Huang, B. Q., Tian, H., & Sun, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1096717 · Cited by 47
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors
Bauer, T. M., Santoro, A., Lin, C., Garrido‐Laguna, I., Joerger, M., Greil, R., Spreafico, A., Yau, T. C. C., Goebeler, M.-E., Hütter‐Krönke, M. L., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007353 · Cited by 46
Inhibition of TGF-β signaling by the fungal lactones (S)-curvularin, dehydrocurvularin, oxacyclododecindione and galiellalactone
Rudolph, K., Serwe, A., & Erkel, G. (2012) · Cytokine · doi:10.1016/j.cyto.2012.10.011 · Cited by 46
MicroRNA-491 regulates the proliferation and apoptosis of CD8+ T cells
Yu, T., Zuo, Q., Gong, L., Wang, L., Zou, Q., & Xiao, B. (2016) · Scientific Reports · doi:10.1038/srep30923 · Cited by 46
Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models
Newsted, D., Banerjee, S., Watt, K., Nersesian, S., Truesdell, P. F., Blazer, L. L., Cardarelli, L., Adams, J., Sidhu, S. S., & Craig, A. W. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1539613 · Cited by 46
Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
Joseph, E. L. M., Laheurte, C., Jary, M., Boullerot, L., Asgarov, K., Gravelin, E., Bouard, A., Rangan, L., Dosset, M., Borg, C., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0326 · Cited by 46
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
Pellegrino, M., Bufalo, F. D., Angelis, B. D., Quintarelli, C., Caruana, I., & de Billy, E. (2020) · Cells · doi:10.3390/cells10010014 · Cited by 48
Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer
Pei, J., Zhang, C., Yusupu, M., Zhang, C., & Dai, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705511 · Cited by 46
Myeloid Cell–Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms
Vasiukov, G., Novitskaya, T., Zijlstra, A., Owens, P., Ye, F., Zhao, Z., Moses, H. L., Blackwell, T. S., Feoktistov, I., & Novitskiy, S. V. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3954 · Cited by 43
Self-citation
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer
Wang, X., Feng, M., Xiao, T., Guo, B., Liu, D., Liu, C., Pei, J., Liu, Q., Xiao, Y. Q., Rosin‐Arbesfeld, R., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01756-y · Cited by 46
Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
Liu, Z., Weng, S., Xu, H., Wang, L., Liu, L., Zhang, Y., Guo, C., Dang, Q., Xing, Z., Lu, T., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.757919 · Cited by 44
The role of TGF-β in the tumor microenvironment of pancreatic cancer
Luo, Q., Hu, Z., Zhao, H., Fan, Y., Tu, X., Wang, Y., & Liu, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.019 · Cited by 48
OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis
Wu, R.-S., Hong, J.-J., Wu, J., Yan, S., Wu, D., Liu, N., Liu, Q., Wu, Q.-W., Xie, Y., Liu, Y.-J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17031 · Cited by 46
PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
Kwon, M., Kim, C. G., Lee, H., Cho, H., Kim, Y., Lee, E. C., Choi, S. J., Park, J., Seo, I., Bogen, B., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0267 · Cited by 44
Serial Analysis of Tracheal Restenosis After 3D-Printed Scaffold Implantation: Recruited Inflammatory Cells and Associated Tissue Changes
Ahn, H.-J., Khalmuratova, R., Park, S. A., Chung, E., Shin, H., & Kwon, S. K. (2017) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-017-0057-y · Cited by 43
Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
Dantonio, P. M., Klein, M., Freire, M. R. V. B., Araujo, C. D. N., Chiacetti, A. C., & Correa, R. G. (2018) · Bioscience Reports · doi:10.1042/bsr20180511 · Cited by 47
Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention
Patel, M. B., Sachidanandan, M., & Adnan, M. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4545-5 · Cited by 45
Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma
Gaydosik, A. M., Queen, D., Trager, M. H., Akilov, O. E., Geskin, L. J., & Fuschiotti, P. (2020) · Blood · doi:10.1182/blood.2019004725 · Cited by 43
Immunoregulatory molecules are master regulators of inflammation during the immune response
de la Fuente, H., Cibrián, D., & Sánchez‐Madrid, F. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.032 · Cited by 43
Cancer Secretomes and Their Place in Supplementing Other Hallmarks of Cancer
Patel, S. J., Wetie, A. G. N., Darie, C. C., & Clarkson, B. D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-06068-2_20 · Cited by 42
A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?
Ayroldi, E., Cannarile, L., Delfino, D. V., & Riccardi, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0558-1 · Cited by 43
Dioscin Inhibits the Invasion and Migration of Hepatocellular Carcinoma HepG2 Cells by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition
Chen, B., Zhou, S., Zhan, Y., Ke, J., Wang, K., Liang, Q., Hou, Y., Zhu, P., Ao, W., Wei, X., et al. (2019) · Molecules · doi:10.3390/molecules24122222 · Cited by 42
Crosstalk among colon cancer-derived exosomes, fibroblast-derived exosomes, and macrophage phenotypes in colon cancer metastasis
Wang, M., Su, Z., & Barnie, P. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106298 · Cited by 42
Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression
Mahmud, Z., Rahman, A., Mishu, I. D., & Kabir, Y. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10024-8 · Cited by 44
Therapeutic targeting of TGF ‐β in lung cancer
Aftabi, S., Behrooz, A. B., Cordani, M., Rahiman, N., Sadeghdoust, M., Aligolighasemabadi, F., Pistorius, S., Alavizadeh, S. H., Taefehshokr, N., & Ghavami, S. (2024) · FEBS Journal · doi:10.1111/febs.17234 · Cited by 42
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial
Malek, E., Rana, P. S., Swamydas, M., Daunov, M., Miyagi, M., Murphy, E., Ignatz-Hoover, J. J., Metheny, L. L., Kim, S.-J., & Driscoll, J. J. (2024) · Nature Communications · doi:10.1038/s41467-024-51442-2 · Cited by 45
Transcriptional Activation by NFκB Increases Perlecan/HSPG2 Expression in the Desmoplastic Prostate Tumor Microenvironment
Warren, C. R., Grindel, B. J., Francis, L. W., Carson, D. D., & Farach‐Carson, M. C. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24788 · Cited by 42

Authors: Yang, L., Pang, Y., & Moses, H. L.
Affiliations: National Institutes of Health (US)
Vanderbilt University (US)
ORCID: Pang, Yanli
Moses, Harold L.
Venue: Trends in Immunology
Publisher: Elsevier BV
Published: 2010-06
Volume: 31
Issue: 6
Pages: 220-227
ISSN: 1471-4906 (ISSN-L)
DOI: 10.1016/j.it.2010.04.002
PMC: PMC2891151
OpenAlex: W2130229338
Cited by: 1,023
References: 87
Citations by year: 2026: 35 · 2025: 73 · 2024: 81 · 2023: 82 · 2022: 87 · 2021: 96 · 2020: 85 · 2019: 78 · 2018: 71 · 2017: 51 · 2016: 37 · 2015: 40 · 2014: 49 · 2013: 50 · 2012: 56
FWCI: 4.42
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (ZIABC011163)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: TGF-beta, tumor microenvironment, tumor progression, immunosuppression, tumor surveillance, CD8+ T cells, natural killer cells, neutrophils, chemokines, cancer-associated fibroblasts, TGF-beta antagonists
MeSH terms: Animals, Humans, Killer Cells, Natural, Neoplasms, T-Lymphocytes, Signal Transduction, Transforming Growth Factor beta, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks